Viewing Study NCT05263050


Ignite Creation Date: 2025-12-24 @ 5:21 PM
Ignite Modification Date: 2026-01-26 @ 4:26 AM
Study NCT ID: NCT05263050
Status: RECRUITING
Last Update Posted: 2025-12-03
First Post: 2022-02-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors
Sponsor:
Organization: